120
Views
29
CrossRef citations to date
0
Altmetric
Research Article

ATP-loaded immunoliposomes specific for cardiac myosin provide improved protection of the mechanical functions of myocardium from global ischemia in an isolated rat heart model

, , , &
Pages 273-280 | Published online: 08 Oct 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Ba Hieu Tran, Ying Yu, Lingling Chang, Bo Tan, Wanwan Jia, Ying Xiong, Tao Dai, Rui Zhong, Weiping Zhang, Van Minh Le, Peter Rose, Zhijun Wang, Yicheng Mao & Yi Zhun Zhu. (2019) A Novel Liposomal S-Propargyl-Cysteine: A Sustained Release of Hydrogen Sulfide Reducing Myocardial Fibrosis via TGF-β1/Smad Pathway. International Journal of Nanomedicine 14, pages 10061-10077.
Read now
Michael Galagudza, Dmitry Korolev, Viktor Postnov, Elena Naumisheva, Yulia Grigorova, Ivan Uskov & Eugene Shlyakhto. (2012) Passive targeting of ischemic-reperfused myocardium with adenosine-loaded silica nanoparticles. International Journal of Nanomedicine 7, pages 1671-1678.
Read now
Kristen Bowey, Jean-François Tanguay & Maryam Tabrizian. (2012) Liposome technology for cardiovascular disease treatment and diagnosis. Expert Opinion on Drug Delivery 9:2, pages 249-265.
Read now
Karona Tep, Virginie Korb, Cyrille Richard, Virginie Escriou, Céline Largeau, Véronique Vincourt, Michel Bessodes, Adeline Guellier, Daniel Scherman, Luc Cynober, Jean-Claude Chaumeil & Gilles Dumortier. (2009) Formulation and evaluation of ATP-containing liposomes including lactosylated ASGPr ligand. Journal of Liposome Research 19:4, pages 287-300.
Read now

Articles from other publishers (25)

Rema Sreenivasan Soumya & Kozhiparambil Gopalan Raghu. (2023) Recent advances on nanoparticle-based therapies for cardiovascular diseases. Journal of Cardiology 81:1, pages 10-18.
Crossref
Rakesh K. Sahoo, Himani Singh, Kamlesh Thakur, Umesh Gupta & Amit K . Goyal. (2022) Theranostic Applications of Nanomaterials in the Field of Cardiovascular Diseases. Current Pharmaceutical Design 28:2, pages 91-103.
Crossref
Ahmed A. H. Abdellatif, Hamdoon A. Mohammed, Riaz A. Khan, Varsha Singh, Abdellatif Bouazzaoui, Mohammad Yusuf, Naseem Akhtar, Maria Khan, Amal Al-Subaiyel, Salman A. A. Mohammed & Mohsen S. Al-Omar. (2021) Nano-scale delivery: A comprehensive review of nano-structured devices, preparative techniques, site-specificity designs, biomedical applications, commercial products, and references to safety, cellular uptake, and organ toxicity. Nanotechnology Reviews 10:1, pages 1493-1559.
Crossref
Dimitrios Skourtis, Dimitra Stavroulaki, Varvara Athanasiou, Panagiota G. Fragouli & Hermis Iatrou. (2020) Nanostructured Polymeric, Liposomal and Other Materials to Control the Drug Delivery for Cardiovascular Diseases. Pharmaceutics 12:12, pages 1160.
Crossref
Morteza Aieneravaie, Jim Q. Ho, Leila Arabi, James Lee, Kirsten Herrera, Syeda Mehreen, Najmeh Javdani, Petrina Georgala, Mohammad Reza Sepand, Marjan Rafat & Steven Zanganeh. 2020. Nanomedicine for Ischemic Cardiomyopathy. Nanomedicine for Ischemic Cardiomyopathy 89 111 .
Marie Rouquette, Sinda Lepetre-Mouelhi & Patrick Couvreur. (2019) Adenosine and lipids: A forced marriage or a love match?. Advanced Drug Delivery Reviews 151-152, pages 233-244.
Crossref
Purnima Gupta, Evelyn Garcia, Amrita Sarkar, Sumit Kapoor, Khadija Rafiq, Hitendra S. Chand & Rahul Dev Jayant. (2019) Nanoparticle Based Treatment for Cardiovascular Diseases. Cardiovascular & Hematological Disorders-Drug Targets 19:1, pages 33-44.
Crossref
Maricla Galetti, Stefano Rossi, Cristina Caffarra, Amparo Guerrero Gerboles & Michele Miragoli. 2019. Exposure to Engineered Nanomaterials in the Environment. Exposure to Engineered Nanomaterials in the Environment 235 262 .
Flavio Dormont, Mariana Varna & Patrick Couvreur. (2018) Nanoplumbers: biomaterials to fight cardiovascular diseases. Materials Today 21:2, pages 122-143.
Crossref
Omar Lozano, Alejandro Torres-Quintanilla & Gerardo García-Rivas. (2018) Nanomedicine for the cardiac myocyte: Where are we?. Journal of Controlled Release 271, pages 149-165.
Crossref
Mónica P. A. Ferreira, Sanjeev Ranjan, Sini Kinnunen, Alexandra Correia, Virpi Talman, Ermei Mäkilä, Brianda Barrios-Lopez, Marianna Kemell, Vimalkumar Balasubramanian, Jarno Salonen, Jouni Hirvonen, Heikki Ruskoaho, Anu J. Airaksinen & Hélder A. Santos. (2017) Drug-Loaded Multifunctional Nanoparticles Targeted to the Endocardial Layer of the Injured Heart Modulate Hypertrophic Signaling. Small 13:33, pages 1701276.
Crossref
József Maléth, Péter Hegyi, Zoltán RakonczayJr.Jr. & Viktória Venglovecz. (2015) Breakdown of bioenergetics evoked by mitochondrial damage in acute pancreatitis: Mechanisms and consequences. Pancreatology 15:4, pages S18-S22.
Crossref
Erik Westein, Ulrike Flierl, Christoph E. Hagemeyer & Karlheinz Peter. (2013) Destination Known: Targeted Drug Delivery in Atherosclerosis and Thrombosis. Drug Development Research 74:7, pages 460-471.
Crossref
Tessa Geelen, Leonie E. Paulis, Bram F. Coolen, Klaas Nicolay & Gustav J. Strijkers. (2013) Passive targeting of lipid-based nanoparticles to mouse cardiac ischemia-reperfusion injury. Contrast Media & Molecular Imaging 8:2, pages 117-126.
Crossref
J. Maléth, Z. RakonczayJrJr, V. Venglovecz, N. J. Dolman & P. Hegyi. (2012) Central role of mitochondrial injury in the pathogenesis of acute pancreatitis. Acta Physiologica 207:2, pages 226-235.
Crossref
Alexander Koshkaryev, Rupa Sawant, Madhura Deshpande & Vladimir Torchilin. (2013) Immunoconjugates and long circulating systems: Origins, current state of the art and future directions. Advanced Drug Delivery Reviews 65:1, pages 24-35.
Crossref
Tessa Geelen, Leonie E. M. Paulis, Bram F. Coolen, Klaas Nicolay & Gustav J. Strijkers. (2012) Contrast-enhanced MRI of murine myocardial infarction - Part I. NMR in Biomedicine 25:8, pages 953-968.
Crossref
Tatyana Levchenko, William Hartner & Vladimir P. Torchilin. 2012. Antibody-Mediated Drug Delivery Systems. Antibody-Mediated Drug Delivery Systems 13 33 .
Tatyana S Levchenko, William C Hartner & Vladimir P Torchilin. (2012) Liposomes for cardiovascular targeting. Therapeutic Delivery 3:4, pages 501-514.
Crossref
Vladimir Torchilin. 2012. Fundamentals and Applications of Controlled Release Drug Delivery. Fundamentals and Applications of Controlled Release Drug Delivery 289 328 .
Valeriy Lukyanenko. 2010. Organelle-Specific Pharmaceutical Nanotechnology. Organelle-Specific Pharmaceutical Nanotechnology 433 447 .
Shimin Liu, Steven R. Levine & H. Richard Winn. (2010) Targeting ischemic penumbra Part I: from pathophysiology to therapeutic strategy. Journal of Experimental Stroke and Translational Medicine 3:1, pages 47-55.
Crossref
Maisie J. Joralemon, Samantha McRae & Todd Emrick. (2010) PEGylated polymers for medicine: from conjugation to self-assembled systems. Chemical Communications 46:9, pages 1377.
Crossref
Tamer A. ElBayoumi & Vladimir P. Torchilin. 2010. Liposomes. Liposomes 1 27 .
Valeriy Lukyanenko. (2007) Delivery of nano-objects to functional sub-domains of healthy and failing cardiac myocytes. Nanomedicine 2:6, pages 831-846.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.